Difficulty: Medium
Average Score: 91%
Practice
Which of the following phenothiazine derivatives may produce cardiac toxicity,including ventricular arrhythmias cardiac conduction block and sudden death?
Correct answer
A
Rationale
In pharmacology, understanding the potential cardiac toxicities of different drug classes is crucial for safe and effective patient care. In this case, the correct answer is A) Thioridazine.
Thioridazine, a phenothiazine derivative, is known to have a higher risk of producing cardiac toxicity compared to other phenothiazines. It can lead to ventricular arrhythmias, cardiac conduction block, and even sudden death. This is due to its propensity to prolong the QT interval, which can predispose patients to life-threatening arrhythmias like Torsades de Pointes.
Chlorpromazine (B), Perphenazine (C), and Fluphenazine (D) are also phenothiazine derivatives commonly used in clinical practice. While they may have their own side effects and toxicities, they are not typically associated with the same degree of cardiac toxicity as thioridazine.
Educationally, this question highlights the importance of knowing the specific adverse effect profiles of individual drugs within the same class. It underscores the need for healthcare providers to be vigilant in monitoring patients on thioridazine for any signs or symptoms of cardiac toxicity, especially in those with preexisting cardiac conditions or taking other medications that can prolong the QT interval. Such knowledge can aid in making informed decisions regarding drug selection and patient management to ensure optimal therapeutic outcomes while minimizing risks.
Thioridazine, a phenothiazine derivative, is known to have a higher risk of producing cardiac toxicity compared to other phenothiazines. It can lead to ventricular arrhythmias, cardiac conduction block, and even sudden death. This is due to its propensity to prolong the QT interval, which can predispose patients to life-threatening arrhythmias like Torsades de Pointes.
Chlorpromazine (B), Perphenazine (C), and Fluphenazine (D) are also phenothiazine derivatives commonly used in clinical practice. While they may have their own side effects and toxicities, they are not typically associated with the same degree of cardiac toxicity as thioridazine.
Educationally, this question highlights the importance of knowing the specific adverse effect profiles of individual drugs within the same class. It underscores the need for healthcare providers to be vigilant in monitoring patients on thioridazine for any signs or symptoms of cardiac toxicity, especially in those with preexisting cardiac conditions or taking other medications that can prolong the QT interval. Such knowledge can aid in making informed decisions regarding drug selection and patient management to ensure optimal therapeutic outcomes while minimizing risks.